Navigation Links
Additional Research Imperative on Lung Cancer in Women

New York – When women think of cancer, it is breast cancer or ovarian cancer, which is feared the most. It might be an eye opener to know that more women actually die of lung// cancer, as revealed in a new report that emerged after a discussion amongst reputed cancer specialists.

Even though men were prone to lung cancer in the past, mainly due to smoking, women seem to be equal targets due to increase in women smokers. In 2000, lung cancer deaths among women went up eight times as compared to the figures in 1960.

New research into the science of lung cancers has indicated that women may be suffering greater risk and may be more vulnerable to the contaminants in tobacco smoke. Other insights have also shown that tumors in women portray mutations in the p53 gene, which is responsible in holding back the formation of tumors.

Despite this, women respond better to cancer treatment than do men. So far, most of the research on cancer has been male centric, therefore there is a need to understand the impact of lung tumors in women. 'An urgent need exists to increase awareness and research funding to improve lung cancer care,' the authors conclude, 'particularly in women.'
'"/>




Page: 1

Related medicine news :

1. Additional Radiotheraphy for Breast Cancer
2. Adding An Additional Drug May Help Patients With Glaucoma
3. Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals
4. No More Additional Cases of Mad Cow Disease in Canada
5. NACO to Introduce 400 Additional AIDS/HIV Screening Centers
6. Analysis Shows Lamictal As An Effective Additional Therapy For Treatment of Grand Mal Seizures
7. Pressing Need for Additional Staff Consultants at NHS
8. NACO Inaugurates 37 Additional HIV Treatment Centers
9. Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine?
10. AIIMS Director Venugopal Removed from Additional Post
11. Kidney Stones - Interesting New Research implicates bacteria as its cause
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... September 25, 2017 , ... Earlypicker is expanding its offerings to include fashion, ... hottest Korean cosmetics and fashion trends sweeping the nation. The decision to expand beyond ... the great offerings that allow Koreans everywhere to look their best every single day. ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Grandpa's Visit”: a ... teach and share with the others. “Grandpa's Visit” is the creation of published author, ... that she is much like the character in her book. She shares, “Mr. Rice ...
(Date:9/25/2017)... CA (PRWEB) , ... September 25, 2017 , ... Azadian ... a full-time office in downtown Los Angeles, to service existing clients in the Western ... areas. , “We are seeing an ever-increasing amount of business demand west of the ...
(Date:9/24/2017)... ... September 25, 2017 , ... Bhowanie Benimadhu’s new book “ Our Creative World: ... life and seeks answers in both Eastern and Western religious traditions and spirituality such ... in the mind of humankind for the past thousands of years and still are,” ...
(Date:9/24/2017)... Turks & Caicos Islands, BWI (PRWEB) , ... September 24, 2017 ... ... Islands, the #1 rated resort on TripAdvisor and one of Provo's premier boutique resorts, ... no reported structural damage to the resort after devastating Hurricanes Irma and more recently ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting at ... Rodman & Renshaw 19 th Annual Global Investment Conference ... p.m. Pacific time). The conference is being held at the ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
Breaking Medicine Technology: